Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2010 2
2012 2
2014 1
2017 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Study protocol for the Fukushima Health Management Survey.
Yasumura S, Hosoya M, Yamashita S, Kamiya K, Abe M, Akashi M, Kodama K, Ozasa K; Fukushima Health Management Survey Group. Yasumura S, et al. J Epidemiol. 2012;22(5):375-83. doi: 10.2188/jea.je20120105. Epub 2012 Aug 25. J Epidemiol. 2012. PMID: 22955043 Free PMC article.
Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study.
Mashiko T, Fujimoto S, Suda S, Abe A, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Todo K, Yamazaki M, Nakajima N, Kondo K, Inoue T, Iwanaga T, Terasawa Y, Shibazaki K, Kimura K; PASTA Investigators. Mashiko T, et al. J Neurol Sci. 2022 Mar 15;434:120163. doi: 10.1016/j.jns.2022.120163. Epub 2022 Jan 26. J Neurol Sci. 2022. PMID: 35121210
A novel partial agonist of GPBA reduces blood glucose level in a murine glucose tolerance test.
Enomoto R, Kurosawa A, Nikaido Y, Mashiko M, Saheki T, Nakajima N, Kuroiwa S, Otobe M, Ohsaki M, Tooyama K, Inoue Y, Kuwabara N, Kikuchi O, Kitamura T, Kojima I, Nakagawa Y, Saito T, Osada H, Futahashi M, Sezutsu H, Takeda S. Enomoto R, et al. Eur J Pharmacol. 2017 Nov 5;814:130-137. doi: 10.1016/j.ejphar.2017.08.017. Epub 2017 Aug 17. Eur J Pharmacol. 2017. PMID: 28823924
Application of the improved BALB/c 3T3 cell transformation assay to the examination of the initiating and promoting activities of chemicals: the second interlaboratory collaborative study by the non-genotoxic carcinogen study group of Japan.
Tsuchiya T, Umeda M, Tanaka N, Sakai A, Nishiyama H, Yoshimura I, Ajimi S, Asada S, Asakura M, Baba H, Dewa Y, Ebe Y, Fushiwaki Y, Hagiwara Y, Hamada S, Hamamura T, Iwase Y, Kajiwara Y, Kasahara Y, Kato Y, Kawabata M, Kitada E, Kaneko K, Kizaki Y, Kubo K, Miura D, Mashiko K, Mizuhashi F, Muramatsu D, Nakajima M, Nakamura T, Oishi H, Sasaki T, Shimada S, Takahashi C, Takeda Y, Wakuri S, Yajima N, Yajima S, Yatsushiro T. Tsuchiya T, et al. Altern Lab Anim. 2010 Mar;38(1):11-27. doi: 10.1177/026119291003800111. Altern Lab Anim. 2010. PMID: 20377301
Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure.
Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y; Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Asayama K, et al. Hypertens Res. 2012 Nov;35(11):1102-10. doi: 10.1038/hr.2012.125. Epub 2012 Aug 16. Hypertens Res. 2012. PMID: 22895063 Clinical Trial.
Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.
Ogihara T, Saruta T, Rakugi H, Saito I, Shimamoto K, Matsuoka H, Shimada K, Ito S, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Kimura G, Umemura S, Ura N, Hayashi K, Odawara M, Tanahashi N, Ishimitsu T, Kashihara N, Morita S, Teramukai S; COLM Investigators. Ogihara T, et al. J Hypertens. 2014 Oct;32(10):2054-63; discussiom 2063. doi: 10.1097/HJH.0000000000000281. J Hypertens. 2014. PMID: 24999799 Free PMC article. Clinical Trial.
An Interlaboratory Validation Study of the Improved Transformation Assay Employing Balb/c 3T3 Cells: Results of a Collaborative Study on the Two-stage Cell Transformation Assay by the Non-genotoxic Carcinogen Study Group.
Tsuchiya T, Umeda M, Nishiyama H, Yoshimura I, Ajimi S, Asakura M, Baba H, Dewa Y, Ebe Y, Fushiwaki Y, Hamada S, Hamamura T, Hayashi M, Iwase Y, Kajiwara Y, Kasahara Y, Kawabata M, Kitada E, Kubo K, Mashiko K, Miura D, Mizuhashi F, Mizuno F, Nakajima M, Nakamura Y, Nobe N, Oishi H, Ota E, Sakai A, Sato M, Shimada S, Sugiyama T, Takahashi C, Takeda Y, Tanaka N, Toyoizumi C, Tsutsui T, Wakuri S, Yajima S, Yajima N. Tsuchiya T, et al. Altern Lab Anim. 1999 Jul-Aug;27(4):685-702. doi: 10.1177/026119299902700409. Altern Lab Anim. 1999. PMID: 25487866
Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study.
Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, Imai Y, Kikuchi K, Ito S, Eto T, Kimura G, Imaizumi T, Takishita S, Ueshima H; Valsartan in Elderly Isolated Systolic Hypertension Study Group. Ogihara T, et al. Hypertension. 2010 Aug;56(2):196-202. doi: 10.1161/HYPERTENSIONAHA.109.146035. Epub 2010 Jun 7. Hypertension. 2010. PMID: 20530299 Clinical Trial.